kernelshap
kernelshap makes permutation SHAP practical past eight features, then fixes the kernel weights it had wrong.
Comparison · Analytics
cfrnow vs monitOS
A side-by-side editorial comparison of cfrnow and monitOS — release velocity, themes, recent moves, and the top alternatives to consider.
cfrnow vs monitOS: at a glance
What is cfrnow?
A Bayesian real-time CFR estimator that now ships stratified fits and posterior-predictive checks
cfrnow estimates case fatality ratios from line-list data while an outbreak is still running, using a Bayesian mixture-cure survival model registered as an `epidist` model type. Three releases in a month took it from first public release to stratified, partially-pooled fits with posterior-predictive checking. It leans on `distspec` for delay parameterisation, which reached CRAN alongside the 0.2.1 patch.
What is monitOS?
monitOS relicenses to MIT, the clearest signal in a sparse Novartis release feed.
monitOS is Novartis's R package for monitoring overall survival in clinical trials, with an accompanying Shiny app. The 0.1.6 release changes the licence to MIT, fixes a shiny import problem and an infinite-value bug in the app, and adds spell checking plus issue-tracker and website links. The prior release carries no notes at all beyond a link to the commit history.
cfrnow vs monitOS: editorial side-by-side
cfrnow
5.0ANALYTICS
A Bayesian real-time CFR estimator that now ships stratified fits and posterior-predictive checks
◆ Current state
cfrnow estimates case fatality ratios from line-list data while an outbreak is still running, using a Bayesian mixture-cure survival model registered as an `epidist` model type. Three releases in a month took it from first public release to stratified, partially-pooled fits with posterior-predictive checking. It leans on `distspec` for delay parameterisation, which reached CRAN alongside the 0.2.1 patch.
◆ Where it's heading
The arc runs from producing a single corrected CFR number toward supporting a full model-checking workflow. 0.2.0 added the pieces a modeller needs to defend an estimate: replicate line lists replayed through the real-time truncation, an ascertainment-ratio correction for when fatal and non-fatal cases enter the line list at different rates, and per-group CFRs from `brms` formulas. Delay coverage widened from LogNormal and Gamma to Weibull in the same release.
◆ Prediction
Expect the next release to keep widening covariate and pooling support rather than adding new outcome types, since every 0.2.0 addition extended the existing formula interface instead of replacing it.
monitOS
0.0ANALYTICS
monitOS relicenses to MIT, the clearest signal in a sparse Novartis release feed.
◆ Current state
monitOS is Novartis's R package for monitoring overall survival in clinical trials, with an accompanying Shiny app. The 0.1.6 release changes the licence to MIT, fixes a shiny import problem and an infinite-value bug in the app, and adds spell checking plus issue-tracker and website links. The prior release carries no notes at all beyond a link to the commit history.
◆ Where it's heading
For a package published by a pharmaceutical sponsor, the licence change is the substantive item — MIT removes friction for reuse outside Novartis, and the added issue link and website point the same way, toward outside users. Everything else is packaging hygiene. At 0.1.6 with two releases nine months apart, the statistical methodology looks settled while the distribution around it is being tidied.
◆ Prediction
The open-sourcing signals suggest the next release will respond to outside issue reports; the entries give no indication of methodology changes.
Alternatives to cfrnow and monitOS
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either cfrnow or monitOS.
filtro
filtro moves to S7 and multiplies its feature-scoring methods in a single release.
modeltime.resample
modeltime.resample exists to keep backtesting working as tidymodels shifts underneath it.
modeltime.ensemble
modeltime.ensemble wakes after four years, and the work is all tune 2.0 compatibility.
shapviz
shapviz refines its SHAP plots release by release while chasing ggplot2's moving target.
hstats
hstats settled into maintenance after its 1.0 restructuring, with model coverage the only thing still growing.
See all cfrnow alternatives → · See all monitOS alternatives →
Recent activity from cfrnow and monitOS
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 5d agocfrnowdistspec dependency moves to CRAN
- 5d agocfrnowStratified CFR fits, Weibull delays, posterior-predictive checks
- 1mo agocfrnowFirst release: real-time CFR from a Bayesian mixture-cure model ⚡
- 1y agomonitOSRelicensed to MIT; Shiny import and inf-value fixes
- 1y agomonitOSv0.1.5-release
Frequently asked questions
What is the difference between cfrnow and monitOS?
They serve adjacent needs but don't currently overlap on shipped themes. cfrnow is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is cfrnow better than monitOS?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. cfrnow is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to cfrnow?
Top cfrnow alternatives in Analytics are ranked by recent ship velocity. Browse the "cfrnow alternatives" section above for the current picks, or visit /alternatives/cfrnow for the full list with editorial commentary on each.
What are the best alternatives to monitOS?
Top monitOS alternatives in Analytics are ranked by recent ship velocity. Browse the "monitOS alternatives" section above for the current picks, or visit /alternatives/monitos for the full list with editorial commentary on each.